Finally, to investigate the pro-fibrotic potential of extracellular IL-33 in IPF, PCLS from normal adjacent tissue (NAT) and IPF lung were stimulated with IL-33 or TGFβ and changes in gene expression and protein levels of fibrotic markers assessed. The gene discussed is IL33; the disease is idiopathic pulmonary fibrosis.